SmartHealth in CPHI Middle East … Active participation and honorable visits.
During our successful participation in the CPHI Middle East exhibition, SmartHealth Company was honored by many visitors and interested parties, where our various activities in the health sector were reviewed, including patient support programs, various training programs, and clinical studies services.
We also received an exceptional visit from His Excellency, the Minister of Health, Mr. Fahd Al-Jalajel, and His Excellency, the CEO of the Food and Drug Authority (SFDA), Dr. Hisham Al- Jadhai, to our booth during the exhibition activities.
During the visit, we reviewed our innovative solutions in supporting patients starting from raising awareness, enhancing diagnosis to improving adherence & compliance through our diversified scope and omnichannel approaches, which enable us to give better treatment experience for patients and their families, in addition to specialized medical and pharmaceutical training programs in line with the goals of the Kingdom’s Vision 2030.
As a SmartHealth team, we extend our sincere thanks and appreciation to His Excellency the Minister for his continuous support for the health sector, as well as Dr. Hisham Ali for leading the pharmaceutical sector in the Kingdom, and we are happy under their leadership and support to continue our role as a strategic partner services to achieve excellence and innovation in healthcare.
